Sandwich ELISA was used to detect P-tau 181 in CSF in 2000, and it was discovered that levels were higher in AD patients relative to age-matched controls, but lower in FTD patients, indicating that CSF P-tau 181 may be a more specific marker for AD (Vanmechelen et al., 2000). This evidence concerns the gene MAPT and Alzheimer disease.